Switch theme
Sign up to access all valuation multiples
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of promising companies.
2001
1
LTM Revenue $104M
LTM EBITDA $73.4M
$1.5B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
HBM Healthcare Inv has a last 12-month revenue (LTM) of $104M and a last 12-month EBITDA of $73.4M.
In the most recent fiscal year, HBM Healthcare Inv achieved revenue of $25.3M and an EBITDA of n/a.
HBM Healthcare Inv expects next 12-month revenue of XXX and NTM EBITDA of XXX
See HBM Healthcare Inv valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $104M | XXX | $25.3M | XXX | XXX | XXX |
| Gross Profit | $104M | XXX | n/a | XXX | XXX | XXX |
| Gross Margin | 100% | XXX | n/a | XXX | XXX | XXX |
| EBITDA | $73.4M | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | 71% | XXX | n/a | XXX | XXX | XXX |
| EBIT | $73.4M | XXX | n/a | XXX | XXX | XXX |
| EBIT Margin | 71% | XXX | n/a | XXX | XXX | XXX |
| Net Profit | $73.4M | XXX | $22.3M | XXX | XXX | XXX |
| Net Margin | 71% | XXX | 88% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $117M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, HBM Healthcare Inv's stock price is CHF 171 (or $205).
HBM Healthcare Inv has current market cap of CHF 1.1B (or $1.4B), and EV of CHF 1.2B (or $1.5B).
See HBM Healthcare Inv trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.5B | $1.4B | XXX | XXX | XXX | XXX | $10.34 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, HBM Healthcare Inv has market cap of $1.4B and EV of $1.5B.
HBM Healthcare Inv's trades at 77.5x EV/Revenue multiple, and n/a EV/EBITDA.
Equity research analysts estimate HBM Healthcare Inv's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
HBM Healthcare Inv has a P/E ratio of 18.8x.
See valuation multiples for HBM Healthcare Inv and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $1.4B | XXX | $1.4B | XXX | XXX | XXX |
| EV (current) | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| EV/Revenue | 14.5x | XXX | 77.5x | XXX | XXX | XXX |
| EV/EBITDA | 20.4x | XXX | n/a | XXX | XXX | XXX |
| EV/EBIT | 20.4x | XXX | n/a | XXX | XXX | XXX |
| EV/Gross Profit | 14.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | 18.8x | XXX | 84.3x | XXX | XXX | XXX |
| EV/FCF | 19.3x | XXX | -568.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHBM Healthcare Inv's last 12 month revenue growth is 54%
HBM Healthcare Inv's revenue per employee in the last FY averaged $25.3M, while opex per employee averaged $3.0M for the same period.
HBM Healthcare Inv's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
HBM Healthcare Inv's rule of X is 205% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for HBM Healthcare Inv and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 54% | XXX | 188% | XXX | XXX | XXX |
| EBITDA Margin | 71% | XXX | n/a | XXX | XXX | XXX |
| EBITDA Growth | 76% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 205% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $25.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $3.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Investcorp Capital | XXX | XXX | XXX | XXX | XXX | XXX |
| Waha Capital | XXX | XXX | XXX | XXX | XXX | XXX |
| ASR Nederland | XXX | XXX | XXX | XXX | XXX | XXX |
| CVC Capital Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Eurocommercial Props | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
HBM Healthcare Inv acquired XXX companies to date.
Last acquisition by HBM Healthcare Inv was XXXXXXXX, XXXXX XXXXX XXXXXX . HBM Healthcare Inv acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was HBM Healthcare Inv founded? | HBM Healthcare Inv was founded in 2001. |
| Where is HBM Healthcare Inv headquartered? | HBM Healthcare Inv is headquartered in Switzerland. |
| How many employees does HBM Healthcare Inv have? | As of today, HBM Healthcare Inv has 1 employees. |
| Is HBM Healthcare Inv publicy listed? | Yes, HBM Healthcare Inv is a public company listed on SWX. |
| What is the stock symbol of HBM Healthcare Inv? | HBM Healthcare Inv trades under HBMN ticker. |
| Who are competitors of HBM Healthcare Inv? | Similar companies to HBM Healthcare Inv include e.g. Investcorp Capital, Waha Capital, ASR Nederland, CVC Capital Partners. |
| What is the current market cap of HBM Healthcare Inv? | HBM Healthcare Inv's current market cap is $1.4B |
| What is the current revenue of HBM Healthcare Inv? | HBM Healthcare Inv's last 12 months revenue is $104M. |
| What is the current revenue growth of HBM Healthcare Inv? | HBM Healthcare Inv revenue growth (NTM/LTM) is 54%. |
| What is the current EV/Revenue multiple of HBM Healthcare Inv? | Current revenue multiple of HBM Healthcare Inv is 14.5x. |
| Is HBM Healthcare Inv profitable? | Yes, HBM Healthcare Inv is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of HBM Healthcare Inv? | HBM Healthcare Inv's last 12 months EBITDA is $73.4M. |
| What is HBM Healthcare Inv's EBITDA margin? | HBM Healthcare Inv's last 12 months EBITDA margin is 71%. |
| What is the current EV/EBITDA multiple of HBM Healthcare Inv? | Current EBITDA multiple of HBM Healthcare Inv is 20.4x. |
| What is the current FCF of HBM Healthcare Inv? | HBM Healthcare Inv's last 12 months FCF is $77.9M. |
| What is HBM Healthcare Inv's FCF margin? | HBM Healthcare Inv's last 12 months FCF margin is 75%. |
| What is the current EV/FCF multiple of HBM Healthcare Inv? | Current FCF multiple of HBM Healthcare Inv is 19.3x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
